At the same time, the mechanisms of resistance to immunotherapy remain a major problem—the absence of neoantigens or abnormal antigen presentation, low tumor load, low PD-L1 expression, impaired T cell infiltration or T cell depletion, the presence of immunosuppressive cells or factors, and in particular the predominance of TAMs in the TME [122]. This evidence concerns the gene CD274 and neoplasm.